Quest Diagnostics Moves to Acquire LifeLabs of Canada

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

QUEST DIAGNOSTICS, ALREADY A CLINICAL LABORATORY BEHEMOTH IN THE U.S., is expanding its Nor…

Read More

---

July 22, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

Some hospitals failing to comply with the federal price transparency regulation have been fined. The website of CMS.gov lists 15 hospitals and the amount each was fined. On June 6, 2022, the first fines were levied against Northside Hospital of Atlanta ($883,130) and Northsid…

Read More

---

New Type of Competition from Investor-Owned Labs

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

CEO SUMMARY: More investor-funded lab companies see robust future growth in serving what The Washington Post calls “a booming online wellness market that aims to leave the doctor’s office behind. ” This is a new market driven by younger health­ care-minded consumers who turn to …

Read More

---

July 1, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

Last week, it was announced that Quest Diagnostics “would acquire select laboratory assets from 12-hospital Allina Health” the Minneapolis-based health sys­tem. Quest stated, “Under the terms of the definitive agree­men…

Read More

---

Is It Time for Clinical Labs to Embrace Consumers?

By R. Lewis Dark | From the Volume XXXI, No. 9 – July 1, 2024 Issue

HEALTHCARE IN THIS COUNTRY HAS A WELL-D…

Read More

---

ACLA Files Court Challenge to FDA’s Final LDT Rule

By Robert Michel | From the Volume XXXI, No. 8 – June 10, 2024 Issue

CEO SUMMARY: Discussing the FDA’s final LDT rule, one pathologist tracking this matter wrote, “In many ways, the FDA’s plan [final LDT rule] is like the guy who gets three wishes from a genie, and he asks for unlimited wishes.” ACLA and HealthTrackRx are challenging the FDA’s �…

Read More

---

ACLA President Van Meter Discusses LDT Lawsuit

By Robert Michel | From the Volume XXXI, No. 8 – June 10, 2024 Issue

CEO SUMMARY: On July 5, the final laboratory developed test (LDT) rule issued by the federal Food and Drug Administration (FDA) takes effect. In response, the American Clinical Laboratory Association (ACLA) filed a lawsuit in federal court in Texas to challenge the FDA’s actions. In thi…

Read More

---

Labcorp, Quest Issue Q1 Earnings, Offer Comments on FDA’s LDT Rule

By Robert Michel | From the Volume XXXI, No. 7 – May 20, 2024 Issue

  BOTH LABCORP, BURLINGTON, N.C., AND QUEST DIAGNOSTICS, SECAUCU…

Read More

---

Lab’s Innovation Center Encourages Staff Ideas

By Robert Michel | From the Volume XXXI, No. 7 – May 20, 2024 Issue

CEO SUMMARY: At a time when health plans consider lab testing a commodity, the team at Sonora Quest Laboratories deliberately set out to encourage ideas and innovation from its staff by creating the “Innovation Center of Excellence.” One innovation involves helping health plans and ph…

Read More

---

Labcorp to Acquire Only Certain Lab Assets of OPKO’s BioReference

By Robert Michel | From the Volume XXXI, No. 6 – April 29, 2024 Issue

Following Labcorp’s announcement that it will acquire “select assets” of BioR…

Read More

---